A CASE OF PELVIC ACTINOMYCOSIS ASSOCIATED WITH AN INTRAUTERINE DEVICE
Abstract
Background. Actinomycosis is a rare slowly progressive infection caused by Gram-positive anaerobic bacteria from the genus Actinomyces. The disease is characterized by the formation of the abscesses surrounded by dense fibrosis that extend slowly across natural anatomic boundaries.
Patients and methods. The case of a 49-year-old patient with pelvic actinomycosis associated with an intrauterine device is presented. The patient was successfully treated with the combination of antibiotic and surgical therapy.
Conclusions. Pelvic actinomycosis is a rare disorder. The infection may occur as a consequence of an abdominal disease or an ascending infection from the genito-urinary tract. Diagnosis of the actinomycosis can be difficult, malignant disease if often suspected. The diagnosis is frequently not established until after surgery.
Downloads
References
Russo TA. Agents of actinomycosis. In: Mandell GL, Bennett JE, Dolin R eds. Principles and practice of infectious diseases. 4th ed. New York: Churchill Livingstone, 1995: 2645–54.
Smego RA Jr, Foglia G. Actinomycosis. Clin Infect Dis 1998; 26:1255–63.
Atad J, Hallak M, Sharon A, Kitzes R, Kelner Y, Abramovici H. Pelvic actinomycosis. Is long-term antibiotic therapy necessary? J Reprod Med 1999; 44: 939–44.
Gorišek B. Aktinomikoza ženskih genitalij. Zdrav Vestn 1984; 53: 443–4.
Fiorino AS. Intrauterine contraceptive device-associated actinomycotic abscess and Actinomyces detection on cervical smear. Obstet Gynecol 1996; 87: 142–9.
Lee YC, Min D, Holcomb K, Buhl A, DiMaio T, Abulafia O. Computed tomography guided core needle biopsy diagnosis of pelvic actinomycosis. Gynecol Oncol 2000; 79: 318–23.
Hamid D, Baldauf JJ, Cuenin C, Ritter J. Treatment strategy for pelvic actinomycosis: case report and review of the literature. Eur J Obstet Gynecol Reprod Biol 2000; 89: 197–200.
Bercovich A, Guy M, Karayiannakis AJ, Gdalia M, Muriel E, Dgani R, Zbar AP. Ureteral obstruction and reconstruction in pelvic actinomycosis. Urology 2003; 61: 224–4.
Nawroth F, Foth D, Schmidt T, Römer T. Differential diagnosis and nonsurgical treatment of pelvic actinomycosis. Acta Obstet Gynecol Scand 2000; 79: 1024–5.
Phupong V, Sueblinvong T, Pruksananonda K, Taneepanichskul S, Triratanachat S. Uterine perforation with Lippes loop intrauterine device-associated actinomycosis a case report and review of the literature. Contraception 2000; 61: 347–50.
Petrone LR, Sivalingam JJ, Vaccaro AR. Actinomycosis—an unusual case of an uncommon disease. J Am Boar Fam Pract 1999; 12: 158–61.
Tedeschi A, Di Mezza G, D’Amico G, Ermann A, Montone L, Siciliano M, Cobellis G. A case of pelvic actinomycosis presenting as cutaneous fistula. Eur J Obstet & Gynecol Reprod Biol 2003; 108: 103–5.
Lippes J. Pelvic actinomycosis: a review and preliminary look at prevalence. Am J Obstet Gynecol 1999; 180: 265–9.
Arend SM, Oosterhof H, van Dissel JT. Actinomyces and the intrauterine device. Arch Intern Med 1998; 8: 1270–0.
Bonacho I, Pita S, Gómez-Besteiro MI. Eight years with the same IUD. Contraception 1999; 59: 233–6.
Muntinghe FLH, Emmen L, Oeseburg HB, Wijnja L. Pelvic actinomycosis 5 years after removal of an intra-uterine contraceptive device. Neth J Med 1999; 55: 160–2.
Merki-Feld GS, Lebeda E, Hogg B, Keller PJ. The incidence of actinomyceslike organisms in Papanicolaou-stained smears of copper- and levonorgestrel-releasing intrauterine devices. Contraception 2000; 61: 365–8.
Russo TA. Actinomycosis. In: Braunwald E, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL eds. Harrison’s principles of internal medicine. 15th ed., London: McGraw-Hill, 2001: 1008–11.
Pretnar-Darovec A. Maternični vložek in vnetje rodil. Zdrav Vestn 1999; 68: 495–8.
Nugteren SK, Ouwendijk RJ, Jonkman JG, Straub M, Dees A. Colitis and lower abdominal mass by Actinomyces israelii in a patient with an IUD. Neth J Med 1996; 49: 73–6.
Nasu K, Matsumoto H, Yoshimatsu J, Miyakawa I. Uretral and sigmoid obstruction caused by pelvic actinomycosis in an intrauterine contraceptive device user. Gynecol Obstet Invest 2002; 54: 228–31.
The Author transfers to the Publisher (Zdravniški vestnik/Slovenian Medical Journal) all economic copyrights following form Article 22 of the Slovene Copyright and Related Rights Act (ZASP), including the right of reproduction, the right of distribution, the rental right, the right of public performance, the right of public transmission, the right of public communication by means of phonograms and videograms, the right of public presentation, the right of broadcasting, the right of rebroadcasting, the right of secondary broadcasting, the right of communication to the public, the right of transformation, the right of audiovisual adaptation and all other rights of the author according to ZASP.
The aforementioned rights are transferred non-exclusively, for an unlimited number of editions, for the term of the statutory
The Author can make use of his work himself or transfer subjective rights to others only after 3 months from date of first publishing in the journal Zdravniški vestnik/Slovenian Medical Journal.
The Publisher (Zdravniški vestnik/Slovenian Medical Journal) has the right to transfer the rights, acquired parties without explicit consent of the Author.
The Author consents that the Article be published under the Creative Commons BY-NC 4.0 (attribution-non-commercial) or comparable licence.
